Most Recent
Companies need to report basis for climate change statements, says ASIC
ASIC has proposed that companies be required to disclose the basis for any forward-looking statements concerning climate, as part of new reporting obligations set to take effect next year.
Investment manager’s not-so ‘Golden Method’ leads to jail time
A former investment manager who provided investors with forged portfolio reports about his 'Golden Method' trading strategy has been sentenced to three years in jail.
Optus slapped with $12m penalty over Triple-0 outage
Optus has been hit with a $12 million penalty over a “preventable” nationwide network outage in November 2023, which left thousands of customers unable to make emergency calls.
Australian Clinical Labs flags strike-out bid in OAIC data breach case
Australian Clinical Labs may seek to strike out part of the OAIC's case over a 2022 data breach, arguing it would unfairly allow the watchdog to allege both single and multiple contraventions of privacy law.
ACCC takes Magnamail to court for misleading prize promotions
Court action by the ACCC alleges mail order company Magnamail made misleading statements to hundreds of thousands of people about prizes they weren't eligible to win.
Ex-boss of AI marketing company Metigy charged with misleading investors
The former CEO of failed AI marketing start-up Metigy has been charged with providing false statements to investors and misusing his position as a director following an investigation by the corporate regulator.
ASIC launches formal MinRes probe over Ellison tax dodge claims
The corporate cop has launched a formal investigation after the airing of tax evasion allegations against Mineral Resources' billionaire founder, Chris Ellison.
Chemist Warehouse, Sigma win ACCC approval for $8.8B merger
The competition regulator has given its blessing to the $8.8 billion merger of Chemist Warehouse and Sigma Healthcare, subject to a promise that franchisees will be free to terminate their contracts.
Blackstone’s bid to acquire I’rom raises competition concerns over clinical trials
The ACCC has red flags about the acquisition of Japanese healthcare business I'rom Group by private equity behemoth Blackstone.
Dixon Advisory director reasonably relied on Minters advice, court finds
A judge has dismissed the corporate regulator’s case alleging former Dixon Advisory director Paul Ryan breached his director’s duties.